<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Sildenafil - Complete Profile</title>
    <link rel="stylesheet" href="/style.css">
</head>

<body>
  <body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/">Home</a>
          </li>
          <li>
            <a href="/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/about/">About</a>
          </li>
          <li>
            <a href="/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/depressants/">Other</a> ‚Üí <span>Sildenafil</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üíô Sildenafil</h1>
        <h2 class="chemical-name">5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-4-one</h2>
          <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="Sildenafil" 
                data-category="Other" 
                data-chemical="5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-4-one">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Brand Names</h4>
              <span>Viagra</span> ‚Ä¢ <span>Revatio</span> ‚Ä¢ <span>Caverta</span> ‚Ä¢ <span>Kamagra</span>
            </div>
            <div class="name-category">
              <h4>Street Names</h4>
              <span>Blue Pills</span> ‚Ä¢ <span>Vitamin V</span> ‚Ä¢ <span>Blue Diamond</span> ‚Ä¢ <span>Love Drug</span>
            </div>
            <div class="name-category">
              <h4>Generic Names</h4>
              <span>Sildenafil Citrate</span> ‚Ä¢ <span>PDE5 Inhibitor</span> ‚Ä¢ <span>Vasodilator</span>
            </div>
            <div class="name-category">
              <h4>Research Codes</h4>
              <span>UK-92480</span> ‚Ä¢ <span>Compound UK-92480</span> ‚Ä¢ <span>Pfizer-VGR100</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category other">Other</span>
          <span class="legal-status prescription">Prescription</span>
          <span class="duration medium">4-6 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/sildenafil.jpg" alt="Sildenafil blue diamond pills" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÇ‚ÇÇH‚ÇÉ‚ÇÄN‚ÇÜO‚ÇÑS</p>
            <p>MW: 474.58 g/mol</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure Sildenafil Citrate</h4>
          <ul>
            <li><strong>Appearance:</strong> White to off-white crystalline powder</li>
            <li><strong>Texture:</strong> Fine crystalline solid</li>
            <li><strong>Odor:</strong> Odorless or nearly odorless</li>
            <li><strong>Taste:</strong> Slightly bitter</li>
            <li><strong>Solubility:</strong> Soluble in water, slightly soluble in ethanol</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Commercial Forms</h4>
          <ul>
            <li><strong>Viagra tablets:</strong> 25mg, 50mg, 100mg (blue diamond-shaped)</li>
            <li><strong>Revatio tablets:</strong> 20mg (white round, for pulmonary hypertension)</li>
            <li><strong>Generic tablets:</strong> Various shapes, colors, dosages</li>
            <li><strong>Liquid forms:</strong> Suspension for injection (Revatio)</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Counterfeit Concerns</h4>
          <p><strong>Online pharmacies:</strong> High risk of counterfeit products with unknown ingredients</p>
          <p><strong>Street sales:</strong> May contain dangerous adulterants or incorrect dosages</p>
          <p><strong>Gas station pills:</strong> Often contain undisclosed PDE5 inhibitors or stimulants</p>
          <p><strong>Herbal supplements:</strong> May contain unlisted sildenafil or analogs</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">10-25mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">25-50mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">50-100mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">100mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Dangerous</span>
          <span class="dose-amount">100mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Medical Dosing Guidelines</h4>
        <ul>
          <li><strong>Erectile dysfunction:</strong> 50mg taken 1 hour before activity (range: 25-100mg)</li>
          <li><strong>Pulmonary hypertension:</strong> 20mg three times daily</li>
          <li><strong>Maximum frequency:</strong> Once per 24 hours for ED</li>
          <li><strong>Food interaction:</strong> High-fat meals delay absorption</li>
          <li><strong>Age considerations:</strong> Lower doses recommended for elderly (‚â•65 years)</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Critical Warning:</strong> Never exceed 100mg in 24 hours. Dangerous interactions with nitrates, alpha-blockers, and other blood pressure medications can cause fatal hypotension.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-1:00</span>
          <span class="effect">Onset - vasodilation begins, mild effects</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+1:00-2:00</span>
          <span class="effect">Peak - maximum erectile function enhancement</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-4:00</span>
          <span class="effect">Plateau - sustained erectile capability</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-6:00</span>
          <span class="effect">Decline - gradual return to baseline</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Therapeutic Effects</h4>
          <ul>
            <li>Enhanced erectile function</li>
            <li>Increased blood flow to genitals</li>
            <li>Improved sexual confidence</li>
            <li>Reduced pulmonary arterial pressure</li>
            <li>Enhanced exercise capacity (PAH patients)</li>
            <li>Potential cognitive benefits (research stage)</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Side Effects</h4>
          <ul>
            <li>Headache (most common)</li>
            <li>Facial flushing</li>
            <li>Nasal congestion</li>
            <li>Visual disturbances (blue tinge)</li>
            <li>Dyspepsia and heartburn</li>
            <li>Priapism (rare but dangerous)</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>Sildenafil is a selective inhibitor of phosphodiesterase type 5 (PDE5), an enzyme that breaks down cyclic guanosine monophosphate (cGMP). By inhibiting PDE5, sildenafil allows cGMP levels to remain elevated, leading to smooth muscle relaxation and vasodilation in the corpus cavernosum of the penis and pulmonary vasculature. This mechanism requires nitric oxide (NO) release for cGMP synthesis, making sildenafil dependent on natural sexual arousal for erectile effects.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>PDE5 (Phosphodiesterase 5)</strong></span>
            <span class="affinity">High selectivity (IC50: 3.5 nM)</span>
            <span class="function">Primary target - maintains cGMP levels for vasodilation</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>PDE6 (Retinal PDE)</strong></span>
            <span class="affinity">Cross-reactivity (IC50: 37 nM)</span>
            <span class="function">Visual side effects - blue tinge, light sensitivity</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>PDE1 (Cardiac/Smooth muscle)</strong></span>
            <span class="affinity">Weak inhibition (IC50: 280 nM)</span>
            <span class="function">Cardiovascular effects, hypotension risk</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>NO/cGMP pathway</strong></span>
            <span class="affinity">Indirect enhancement</span>
            <span class="function">Amplifies natural nitric oxide signaling</span>
          </div>
        </div>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> Hepatic metabolism via CYP3A4 (major) and CYP2C9 (minor)</p>
          <p><strong>Active Metabolite:</strong> N-desmethyl sildenafil (UK-103320) - 50% potency of parent</p>
          <p><strong>Half-life:</strong> 3-5 hours (parent), 4-6 hours (active metabolite)</p>
          <p><strong>Bioavailability:</strong> 40% oral (extensive first-pass metabolism)</p>
          <p><strong>Peak plasma:</strong> 0.5-2 hours (delayed with food)</p>
          <p><strong>Elimination:</strong> 80% feces, 13% urine</p>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <div class="neurotoxicity-info">
          <p><strong>Tissue selectivity:</strong> Preferential action in corpus cavernosum and pulmonary vessels</p>
          <p><strong>cGMP dependence:</strong> Requires NO-stimulated cGMP synthesis for effect</p>
          <p><strong>Physiological amplification:</strong> Enhances natural arousal pathways rather than creating artificial erection</p>
          <p><strong>Cardioprotective potential:</strong> Research suggests benefits for heart health through NO pathway</p>
        </div>

        <h4>Secondary Pharmacological Effects</h4>
        <ul>
          <li><strong>Pulmonary vasodilation:</strong> Reduces pulmonary arterial pressure (Revatio indication)</li>
          <li><strong>Cognitive effects:</strong> Potential neuroprotective properties under investigation</li>
          <li><strong>Exercise performance:</strong> Improved oxygen delivery at altitude</li>
          <li><strong>Cardioprotection:</strong> Preconditioning effects against ischemia-reperfusion injury</li>
          <li><strong>Anti-inflammatory:</strong> Potential reduction of vascular inflammation</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Nitrate interaction:</strong> Can cause fatal drop in blood pressure</li>
            <li><strong>Priapism risk:</strong> Erections lasting >4 hours require emergency care</li>
            <li><strong>Cardiovascular stress:</strong> Dangerous for unstable heart conditions</li>
            <li><strong>Vision loss:</strong> Rare cases of sudden blindness (NAION)</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Precautions</h4>
          <ul>
            <li>Medical evaluation before first use</li>
            <li>Check all medications for interactions</li>
            <li>Never combine with nitrates or poppers</li>
            <li>Avoid excessive alcohol consumption</li>
            <li>Seek immediate help for prolonged erections</li>
            <li>Report sudden vision or hearing changes</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Contraindications</h4>
        <p><strong>Absolute:</strong> Concurrent nitrate use, severe cardiac disease, recent stroke/MI. <strong>Relative:</strong> Hypotension, retinitis pigmentosa, severe liver/kidney disease, bleeding disorders.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Dangerous</h4>
          <ul>
            <li><strong>Nitrates:</strong> Severe hypotension, cardiac arrest, death</li>
            <li><strong>Alpha-blockers:</strong> Additive hypotensive effects</li>
            <li><strong>Riociguat:</strong> Severe hypotension</li>
            <li><strong>Amlodipine:</strong> Increased sildenafil exposure</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° Risky</h4>
          <ul>
            <li><strong>CYP3A4 inhibitors:</strong> Increased sildenafil levels (ketoconazole, ritonavir)</li>
            <li><strong>Other PDE5 inhibitors:</strong> Additive effects, overdose risk</li>
            <li><strong>Blood pressure medications:</strong> Enhanced hypotensive effects</li>
            <li><strong>Alcohol:</strong> Increased risk of hypotension and dizziness</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Caution</h4>
          <ul>
            <li><strong>Grapefruit juice:</strong> May increase sildenafil exposure</li>
            <li><strong>CYP3A4 inducers:</strong> Reduced sildenafil efficacy</li>
            <li><strong>Warfarin:</strong> Monitor bleeding time</li>
            <li><strong>Bosentan:</strong> Reduced sildenafil effectiveness</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Prescription Required</strong> - FDA approved for ED and PAH. Generic versions available since 2017.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Prescription/OTC</strong> - Available by prescription and over-the-counter with pharmacist consultation.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá™üá∫ European Union</h4>
            <p><strong>Prescription Medicine</strong> - Varies by country, some allow OTC sales with restrictions.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¶üá∫ Australia</h4>
            <p><strong>Prescription Only</strong> - TGA approved, generic versions available.</p>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Medical Status</h4>
          <p>Approved for erectile dysfunction and pulmonary arterial hypertension. Research ongoing for additional cardiovascular, neurological, and altitude-related applications.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1989</span>
          <p>Originally developed by Pfizer as UK-92480 for angina treatment</p>
        </div>
        <div class="history-event">
          <span class="year">1991-1992</span>
          <p>Phase I trials reveal unexpected erectile effects in male volunteers</p>
        </div>
        <div class="history-event">
          <span class="year">1994</span>
          <p>Patent filed for erectile dysfunction treatment</p>
        </div>
        <div class="history-event">
          <span class="year">1998</span>
          <p>FDA approves Viagra - first oral ED treatment</p>
        </div>
        <div class="history-event">
          <span class="year">2005</span>
          <p>Revatio approved for pulmonary arterial hypertension</p>
        </div>
        <div class="history-event">
          <span class="year">2017</span>
          <p>Patent expires, generic sildenafil becomes widely available</p>
        </div>
        <div class="history-event">
          <span class="year">2020s</span>
          <p>Research expands into COVID-19, Alzheimer's, and athletic performance</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Cultural Impact</h4>
        <p>Sildenafil revolutionized both sexual medicine and cultural conversations about masculinity, aging, and performance. It transformed erectile dysfunction from a shameful secret to a treatable medical condition, while also creating new recreational drug markets and raising questions about enhancement versus treatment in healthy individuals.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Alzheimer's Disease</h4>
          <p>Large-scale studies investigating sildenafil's potential to reduce Alzheimer's risk through improved cerebral blood flow and neuroplasticity.</p>
        </div>
        
        <div class="research-item">
          <h4>COVID-19 Treatment</h4>
          <p>Clinical trials examining sildenafil's ability to improve oxygenation and reduce mortality in severe COVID-19 pneumonia.</p>
        </div>
        
        <div class="research-item">
          <h4>Athletic Performance</h4>
          <p>Research into sildenafil's effects on exercise capacity, particularly at high altitude where oxygen delivery is compromised.</p>
        </div>
        
        <div class="research-item">
          <h4>Heart Failure</h4>
          <p>Ongoing studies investigating cardioprotective effects and potential benefits in heart failure with preserved ejection fraction.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><a href="https://www.viagra.com/">Official Viagra Website</a> - Pfizer's patient resources</li>
          <li><a href="https://www.drugs.com/viagra.html">Drugs.com</a> - Comprehensive prescribing information</li>
          <li><a href="https://medlineplus.gov/druginfo/meds/a698016.html">MedlinePlus</a> - Patient-friendly drug information</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Safety & Support</h4>
        <ul>
          <li><a href="https://www.issm.info/">ISSM</a> - International Society for Sexual Medicine</li>
          <li><a href="https://www.auanet.org/">AUA</a> - American Urological Association guidelines</li>
          <li><a href="https://www.fda.gov/drugs/drug-safety-and-availability">FDA Drug Safety</a> - Safety communications and alerts</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Research & Education</h4>
        <ul>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed</a> - Scientific literature on sildenafil</li>
          <li><a href="https://clinicaltrials.gov/">ClinicalTrials.gov</a> - Ongoing sildenafil research</li>
          <li><a href="https://www.cochrane.org/">Cochrane Reviews</a> - Evidence-based medicine reviews</li>
        </ul>
      </div>
    </div>
  </div>

</div>
    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/js/lunr.min.js"></script>
    <script src="/assets/js/search.js"></script>
    <script src="/assets/js/substance-integration.js"></script>
</body>
</html>